Digital therapeutics firm HealthBeacon to raise €25m from Irish Stock Exchange IPO

The money from the flotation will be used to grow the company's workforce, boost its working capital, and invest in technology R&D

HealthBeacon, which makes self-medication kits for people who regularly take injectable treatment at home, aims to raise gross proceeds of €25m to help to fund its development.

Irish healthcare services company HealthBeacon is to float its shares on the Irish Stock Exchange with the aim of raising gross proceeds of €25m to help to fund its development.

HealthBeacon is a digital therapeutics firm which makes self-medication kits for people who regularly take injectable treatment at home.